| News | Contents | Scribe Fall 2000 | Next Article | Previous Article |
Examining long-term consequences of methamphetamine use
|
Although the brain has incredible reserve power, Dr. Schuster believes that people who have used high doses of methamphetamine will eventually lose some cognitive ability.
|
|
High
doses of methamphetamine have a clear physiological effect on the brain,
but its long-term effects on people’s ability to function are
uncertain. With more than $1 million from the National Institutes of
Health, Dr. Charles Schuster is using PET imaging and specialized
neurocognitive tests to determine whether or not methamphetamine (MA)
causes a deficiency in brain function. “The
loss of functional ability has been evidenced in animals, but it’s
harder to pinpoint in humans,” said Dr. Schuster, professor of
psychiatry and behavioral neurosciences. Levels of important brain
chemicals, namely dopamine and serotonin, can be reduced by 50 percent
in MA abusers, but behavioral symptoms are generally not detected until
depletion reaches 70 or 80 percent. Dr. Schuster likens this puzzle to
patients with Parkinson’s disease who display severe neurological
impairments by the time they have lost 90 percent of the dopamine in
their system. Still, at a 75 percent loss, they are completely
asymptomatic. The loss of brain function can not be detected until it is
too late. “We
know that there is a gradual loss of serotonin and dopamine with the
normal aging process,” said Dr. Schuster. “We need to know how
dramatic that normal loss may be if combined with a drastic loss of
dopamine from previous experience with drug abuse. A person may have no
detectable brain deficiencies until they reach a particular threshold.
At the moment, however, we can’t pinpoint that threshold,” he said. A current study, being conducted by Dr. Schuster and his research team, will assess neurological functioning in people who have used high doses of methamphetamine in the past. Patient enrollment is currently underway in conjunction with collaborators from the University of Michigan, Haight-Ashbury Free Clinic, Sinai Hospital, and the University of Cambridge. To refer patients or get more information, call (313) 993-3960 or (888) 457-3744.
|
| News | Contents | Scribe Fall 2000 | Next Article | Previous Article |